Home / Generics

Generics

News

First celecoxib generics hit US market posted 12/12/2014

On 10 December 2014, generics makers Actavis, Mylan and Teva Pharmaceutical Industries (Teva) announced that they had all lau...

FDA withdraws automatic substitution of two methylphenidate generics posted 01/12/2014

The US Food and Drug Administration (FDA) announced on 13 November 2014 that it had withdrawn the bioequivalence rating for t...

Cipla petitions Indian Government to revoke Onbrez patents posted 21/11/2014

India-based generics maker Cipla has asked the Indian Government to revoke five patents held by Swiss firm Novartis for its r...

FDA revokes Ranbaxy’s esomeprazole and valganciclovir ANDAs posted 21/11/2014

India-based generics maker Ranbaxy Laboratories (Ranbaxy) announced on 6 November 2014 that the company had been informed by...

Mylan latest to recall blood pressure generics posted 21/11/2014

US generics giant Mylan has become the latest in a line of generics companies that have faced recalls of the blood pressure m...

 

Research

Canada’s generics are too expensive posted 12/12/2014

The same generics cost more in Canada than they do in similarly developed countries. In response to this, the premiers of eac...

Irish pharmacists’ perceptions and attitudes towards generics posted 12/12/2014

In June 2013, new legislation came into effect in Ireland - the Health (Pricing and Supply of Medical Goods) Act 2013 - that...

Generics losing out to brand-name drugs in Croatia posted 12/12/2014

A combination of weak national guidelines and powerful marketing by the pharmaceutical industry has led to a rise in brand-na...

Changes to pharmaceutical policy during an economic recession posted 12/12/2014

The use of antipsychotic medicines across Finland and Portugal following the recent economic recession have been analysed in...

Reference pricing and generics in Finland posted 12/12/2014

Reference pricing and the extension of generics substitution have produced substantial savings in antipsychotic medication co...

 

General

EU Member States suspend generics approvals due to problems at CRO posted 15/12/2014

The European Medicines Agency (EMA) announced on 5 December 2014 that some Member States have decided to suspend the marketin...

Investigation into huge price increases for generics in the US posted 21/11/2014

Two US Congressmen have sent letters to 14 drug manufacturers, including several major Indian firms, requesting information a...

Canada partially lifts import ban on Indian manufacturing sites posted 14/11/2014

In an attempt to avert drug shortages, Canada’s drug regulatory agency, Health Canada, has partially lifted an import ban on...

FDA names and shames firms for failing to pay generics fees posted 27/10/2014

No less than 28 generics makers are currently on the US Food and Drug Administration’s (FDA) GDUFA (Generic Drug User Fee Ame...

Canada bans imports from three API facilities in India posted 17/10/2014

Just days after Canada’s regulatory agency was reported to be in talks with the US Food and Drug Administration (FDA) about C...

Generics News Research General

more

Biosimilars News Research General

more